Cone Health Ventures
Overview
Cone Health Ventures identifies entrepreneurial companies with solutions that address the greatest needs and top strategic aims of Cone Health. Through negotiating win-win co-development agreements to align the interests of all parties, Cone Health Ventures accelerates commercialization into the broader healthcare market, ultimately creating value for the companies, Cone Health, and the patients they serve.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Fuse Oncology | Jun 2023 | Series A | Lead |
| Medicom Technologies Inc. | Jul 2024 | Strategic | Co-investor |
| SiteLabs | Nov 2023 | Seed | Co-investor |
| Centivo | Sep 2024 | Debt & Equity | Co-investor |
Key People
David Heenan
Managing Director
Carter Smith
Venture Principal
James Bauler
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cone Health Ventures based?
Cone Health Ventures is headquartered in Greensboro, North Carolina, United States.
When was Cone Health Ventures founded?
Cone Health Ventures was founded in 2020.
How many portfolio companies does Cone Health Ventures have?
Cone Health Ventures has 4 portfolio companies in Caplight's dataset.
What are some companies in Cone Health Ventures's portfolio?
Portfolio companies visible on Caplight include Fuse Oncology, Medicom Technologies Inc., SiteLabs, Centivo.
What was Cone Health Ventures's most recent investment shown here?
Cone Health Ventures's most recent investment in this portfolio sample was in Centivo in 2024.
What sectors does Cone Health Ventures focus on?
Cone Health Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software.
What company stages does Cone Health Ventures focus on?
Cone Health Ventures typically invests at the MultiStage stage.
What is Cone Health Ventures's AUM?
Cone Health Ventures's assets under management are estimated between $0.0 and $50.0M.